Maximus (MMS) FY2026 10-K: $393M Profit, $112M Operating Cash, and Where the Gap Went
Listen to this report
The Hook
Maximus $MMS closed fiscal 2026 with net income of $392.6M, up from $319.0M, and diluted EPS of $7.27, up from $5.51. Its operations produced $112.4M of cash. That is 29 cents of cash for every dollar of profit, against $1.35 the year before, and it came after the company sold $1.61B of its receivables to Wells Fargo during the year, more than double the $732.1M it sold in fiscal 2025. StockStory's November 19 report on why the shares were sliding cited a fiscal 2027 EPS guide 7.3% below consensus. The 10-K says the bigger question is the cash: receivables rose $437M in a year, the buybacks were paid for with new debt, and the $700M to $800M of free cash flow guided for fiscal 2027 is, by the company's own account, partly fiscal 2026's cash arriving late.
Company Snapshot
Maximus runs government programs under contract: medical disability exams for the Department of Veterans Affairs, the 1-800-MEDICARE and federal ACA marketplace contact centers for CMS, state Medicaid eligibility and enrollment work, and employment services abroad. Its 10-K for the fiscal year ended September 30, 2026, filed November 19, says about 56% of revenue came from the U.S. federal government, about 34% from state and local agencies, about 60% from its ten largest contracts, and about one-fifth from contracts with a single federal agency. One day before the filing, on November 18, it closed the $660M purchase of Agile Defense, a defense IT contractor.
The Financial Story
The income statement improved while revenue shrank. Revenue fell 3.7% to $5,230.8M, yet operating income rose to $613.5M from $528.3M, lifting the operating margin to 11.7% from 9.7%. U.S. Federal Services drove the operating side: its operating income rose $72.3M to $541.5M on revenue that fell 2.5% to $2,992.0M, and its margin went to 18.1% from 15.3%. Total segment operating income rose only $25.9M, to $688.7M from $662.8M, because U.S. Services and Outside the U.S. fell $46.4M between them; the rest of the consolidated gain came from below the segments, a $49.8M swing to $10.2M of divestiture-related gains from $39.5M of charges, and $10.9M less amortization. The 10-K explains the size of that jump in one sentence: VA exam incentive payments, paused in the fourth quarter by a contract modification, "previously provided approximately $25 million of revenue and profit quarterly." The earnings release puts the fiscal 2026 total at an estimated $75M, or $1.05 a share, earned across the first three quarters. Three quarters of incentives roughly equal the segment's entire profit increase. Management guides the segment's fiscal 2027 margin to 14% to 15%.
The cash did not follow the profit. The cash flow statement shows a $442.2M build in accounts receivable, against $31.9M in fiscal 2025. Net receivables ended the year at $1,335.0M, up 48.7%. Billed receivables rose to $874.0M from $720.5M, and unbilled receivables, work performed but not yet invoiced, rose 151% to $471.0M from $187.4M. Days sales outstanding reached 93, against 62 a year earlier. The receivables note says Maximus sold $1.61B of receivables to Wells Fargo under its purchase agreement in fiscal 2026 and booked the $1.60B it received in operating cash flow; the 10-K now gives that facility a $350.0M cap, where last year's said $250.0M. Without the facility the operating cash figure would have been lower still, by whatever balance was sold and uncollected at year end, a number the filing does not give.
| Fiscal 2026, by quarter | Operating cash flow | Buybacks (cash) | Shares bought | Receivables, net (end) |
|---|---|---|---|---|
| Q1 (Dec 2025) | -$244.4M | $40.6M | 0.4M | $1,147.7M |
| Q2 (Mar 2026) | $189.5M | $114.4M | 1.4M | $1,115.0M |
| Q3 (Jun 2026) | -$125.0M | $49.9M | 0.8M | $1,382.0M |
| Q4 (Sep 2026) | $292.3M | $0 | 0 | $1,335.0M |
Quarterly figures are the differences between the year-to-date amounts in the three 10-Qs and the 10-K; share counts are as tagged, rounded to 0.1M.
The buybacks were borrowed. Free cash flow, operating cash less $43.3M of capital spending, was $69.1M. Maximus paid $204.9M for buybacks and $68.7M in dividends, $273.6M in all, about four times what the business generated. Borrowings of $1,708.7M against repayments of $1,444.9M added $263.8M of net debt, and debt principal ended the year at $1,614.6M, up from $1,346.9M, after a $325M increase to its Term Loan B in May. The buying stopped when the cash did: nothing in the fourth quarter, and the full $400.0M authorization set in May was still unused at year end. Over the year the company retired 2.551M shares at a cost of $192.4M, an average of about $75 a share. Then Agile added $295M of new term loans and a revolver draw, which the release says lifts pro forma leverage to about 2.3 times.
Customer money sits in the year-end cash total. Restricted cash, mostly money held for customers, rose to $101.1M from $38.1M, and a $67.5M inflow labeled "Other, including customer escrowed funds" sits in financing, not operations. Both are inside the $381.1M of cash, cash equivalents and restricted cash the cash flow statement ends on; cash and equivalents alone rose $57.6M to $280.0M. On tax, Maximus was charged $129.2M and paid $111.2M, down from $149.9M paid in fiscal 2025, which the 10-K credits partly to recent federal legislation.
Fiscal 2027's cash is partly fiscal 2026's. The 10-K says Maximus collected more than $330M of past-due invoices from a single large federal customer after September 30. The earnings release says that money "had been anticipated in our fiscal year 2026 guidance," and that the fiscal 2027 free cash flow outlook of $700M to $800M "includes the benefit of collections that shifted beyond fiscal year-end" and assumes DSO returns to 60 to 70 days. At the roughly $14.4M of revenue per day implied by the year-end DSO, each 10 days of DSO is worth about $144M, so a return to 65 days would release about $400M on its own (our arithmetic). Put the two years together and fiscal 2026's $69.1M plus the $750M midpoint averages about $410M a year. That is a little above fiscal 2025's $366.2M, and below the $425M to $475M the company guided for fiscal 2026 as late as August.
Valuation: what it's worth as a normal business
Where it trades. At $62.79 (the November 20 close, per stockanalysis.com on November 21), the 52,545,106 shares on the 10-K cover are worth $3.30B. With $1.32B of net debt at September 30 and the roughly $662M Agile outlay, funded mostly with new debt, pro forma enterprise value is about $5.28B, or 7.4 times the roughly $710M of adjusted EBITDA implied by the fiscal 2027 guide (a 12.8% margin on the $5.55B revenue midpoint, with ten months of Agile). Stockanalysis.com on November 21 listed trailing EV/EBITDA of 11.3 for SAIC, 11.4 for Booz Allen and 14.5 for CACI, and a two-analyst consensus target of $92.50 for Maximus. StockStory reported on November 19 that the $7.75 EPS guide midpoint was 7.3% below consensus, and that the shares were down 28.2% for the year.
Scenario DCF. We value unlevered free cash flow at the house 9% discount rate and treat Agile as worth what was paid for it, so its cost and the debt that funded it net out. The base starting cash flow is about $410M: fiscal 2026's $69.1M plus the $330M collected late, less the roughly $56M of after-tax incentive profit that is gone, plus after-tax interest. The bear case cuts terminal growth to 2% because one-fifth of revenue rides on one agency whose exam contracts are being rebid.
| Scenario | Starting unlevered FCF | Growth, years 1-5 | Terminal growth | Enterprise value | Value per share |
|---|---|---|---|---|---|
| Bear | $360M | 0% | 2% | $4.81B | about $66 |
| Base | $410M | 2% | 3% | $6.74B | about $103 |
| Bull | $460M | 4% | 3% | $8.25B | about $132 |
Peer re-rating. On the guided $710M of EBITDA and about $1.98B of pro forma net debt, 8 times gives about $70 a share, 10 times about $97, and the 11.3 times SAIC trades at about $115. The implied range under these assumptions is roughly $66 to $132, with today's price sitting on the bear case: it is consistent with about $280M a year of unlevered cash flow growing 2%, well under the $366.2M of free cash flow (after interest) the company produced in fiscal 2025. This is implied value under stated assumptions, not a price target and not investment advice.
Risks
The VA exam work is the center of the risk list, and the 10-K says so in new words. Last year's risk factor warned about a significant contract being terminated or reduced; this year's adds "modified, such that the modified contract resulted in an unfavorable financial impact," and names "our rebid with the VA" as a case that could force impairment charges. The balance sheet carries $353.9M of intangible assets from the 2021 acquisition that supports those VA contracts, beside $1,780.6M of goodwill. Backlog fell to $13,761M from $15,327M, and federal backlog to $6,895M from $9,780M, while U.S. Services backlog rose to $5,431M from $3,916M. Only about $280M of that backlog counts as remaining performance obligations under GAAP; the rest is option periods and estimated volumes. And the first quarter is the hard one for cash: operating cash flow was -$244.4M in the first quarter of fiscal 2026, now with more debt to service at a 5.81% effective rate.
The Bottom Line
Maximus earned more in fiscal 2026 on less revenue, helped by an estimated $75M of VA incentive revenue that is now paused and that the fiscal 2027 guide assumes will not return. The guide does not settle the cash: a year in which receivables swallowed $442.2M, the buyback was funded with debt, and the receivables facility was run at more than twice last year's volume. The next two quarters will show whether the $330M collected after year end was the start of a return to 60-to-70-day DSO or a one-off catch-up, and whether the fiscal 2027 cash guide survives a seasonally weak first quarter and the VA rebid. Watch DSO, unbilled receivables and the year-end balance sold to Wells Fargo, should the company start reporting it.
No analyst keyed these numbers in. Every figure about Maximus's business came out of its SEC filings: the 10-K and 10-Qs, read as XBRL, and the earnings releases it filed on Form 8-K. The same pipeline reads any of the companies that file with the SEC; a private company's books reported in the same format are the same job.
Figures from Maximus, Inc.'s 10-K for the fiscal year ended September 30, 2026, its fiscal 2026 10-Qs and its August 6 and November 19, 2026 earnings releases (Form 8-K), read through RoboSystems.
Ask the filing yourself
Every figure in this report came from Maximus, Inc.'s SEC filings in the RoboSystems SEC Shared Repository. Connect it to Claude or ChatGPT and ask your own questions, starting with this one:
How much cash did Maximus's operations generate in fiscal 2026 compared with its net income, and how did that ratio compare with fiscal 2025?